Variation around the dominant viral genome sequence contributes to viral load and outcome in patients with Ebola virus disease
-
Published:2020-09-07
Issue:1
Volume:21
Page:
-
ISSN:1474-760X
-
Container-title:Genome Biology
-
language:en
-
Short-container-title:Genome Biol
Author:
Dong Xiaofeng, Munoz-Basagoiti Jordana, Rickett Natasha Y., Pollakis Georgios, Paxton William A., Günther Stephan, Kerber Romy, Ng Lisa F. P., Elmore Michael J., Magassouba N’faly, Carroll Miles W., Matthews David A., Hiscox Julian A.ORCID
Abstract
Abstract
Background
Viral load is a major contributor to outcome in patients with Ebola virus disease (EVD), with high values leading to a fatal outcome. Evidence from the 2013–2016 Ebola virus (EBOV) outbreak indicated that different genotypes of the virus can have different phenotypes in patients. Additionally, due to the error-prone nature of viral RNA synthesis in an individual patient, the EBOV genome exists around a dominant viral genome sequence. The minor variants within a patient may contribute to the overall phenotype in terms of viral protein function. To investigate the effects of these minor variants, blood samples from patients with acute EVD were deeply sequenced.
Results
We examine the minor variant frequency between patients with acute EVD who survived infection with those who died. Non-synonymous differences in viral proteins were identified that have implications for viral protein function. The greatest frequency of substitution was identified at three codon sites in the L gene—which encodes the viral RNA-dependent RNA polymerase (RdRp). Recapitulating this in an assay for virus replication, these substitutions result in aberrant viral RNA synthesis and correlate with patient outcome.
Conclusions
Together, these findings support the notion that in patients who survived EVD, in some cases, the genetic variability of the virus resulted in deleterious mutations that affected viral protein function, leading to reduced viral load. Such mutations may also lead to persistent strains of the virus and be associated with recrudescent infections.
Publisher
Springer Science and Business Media LLC
Reference51 articles.
1. Carroll MW, Matthews DA, Hiscox JA, Elmore MJ, Pollakis G, Rambaut A, Hewson R, Garcia-Dorival I, Bore JA, Koundouno R, et al. Temporal and spatial analysis of the 2014-2015 Ebola virus outbreak in West Africa. Nature. 2015(524):97–101. 2. Kerber R, Krumkamp R, Diallo B, Jaeger A, Rudolf M, Lanini S, Bore JA, Koundouno FR, Becker-Ziaja B, Fleischmann E, et al. Analysis of diagnostic findings from the European Mobile Laboratory in Gueckedou, Guinea, March 2014 through March 2015. J Infect Dis. 2016(214):S250–7. 3. Diehl WE, Lin AE, Grubaugh ND, Carvalho LM, Kim K, Kyawe PP, McCauley SM, Donnard E, Kucukural A, McDonel P, et al. Ebola virus glycoprotein with increased infectivity dominated the 2013-2016 epidemic. Cell. 2016(167):1088–98 e1086. 4. Urbanowicz RA, McClure CP, Sakuntabhai A, Sall AA, Kobinger G, Muller MA, Holmes EC, Rey FA, Simon-Loriere E, Ball JK. Human adaptation of Ebola virus during the West African outbreak. Cell. 2016;167:1079–87 e1075. 5. Liu X, Speranza E, Munoz-Fontela C, Haldenby S, Rickett NY, Garcia-Dorival I, Fang Y, Hall Y, Zekeng EG, Ludtke A, et al. Transcriptomic signatures differentiate survival from fatal outcomes in humans infected with Ebola virus. Genome Biol. 2017;18:4.
Cited by
18 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|